General description Patient derived organoids (PDOs) are novel in vitro 3D cell models that preserve original tissue physiology and molecular pathology, thus representing a clinically-relevant alternative to traditional 2D cell lines and an
General description Patient derived organoids (PDOs) are novel in vitro 3D cell models that preserve original tissue physiology and molecular pathology, thus representing a clinically-relevant alternative to traditional 2D cell lines and an
DECON-SPORE 200 Plus is a EPA registered Peracetic Acid and Hydrogen Peroxide solution that is for use as a sanitizer, disinfectant, virucide, sterilant sporicide, and deodorizer in pharmaceutical, biotechnology, medical device, hospital, and lab
DECON-SPORE 200 Plus is a EPA registered Peracetic Acid and Hydrogen Peroxide solution that is for use as a sanitizer, disinfectant, virucide, sterilant sporicide, and deodorizer in pharmaceutical, biotechnology, medical device, hospital, and lab
GVS capsules are disposable filtration units designed for the removal of particles or bacteria from aqueous or solvent solutions and gas streams. They are ready to use, eliminating the need to disassemble, clean, and reassemble filter housings.
GVS capsules are disposable filtration units designed for the removal of particles or bacteria from aqueous or solvent solutions and gas streams. They are ready to use, eliminating the need to disassemble, clean, and reassemble filter housings.
PSB-12379, a nucleotide analogue, is a potent Ecto-5'-Nucleotidase ( CD73 ) inhibitor with K i s of 9.03 nM (rat) and 2.21 nM (human)In VitroMetabolism : Only a small percentage (<:23%) of PSB-12379 (10g) is metabolized under the applied
PSB-12379, a nucleotide analogue, is a potent Ecto-5'-Nucleotidase ( CD73 ) inhibitor with K i s of 9.03 nM (rat) and 2.21 nM (human)In VitroMetabolism : Only a small percentage (<:23%) of PSB-12379 (10g) is metabolized under the applied
PSB-12379, a nucleotide analogue, is a potent Ecto-5'-Nucleotidase ( CD73 ) inhibitor with K i s of 9.03 nM (rat) and 2.21 nM (human)In VitroMetabolism : Only a small percentage (<:23%) of PSB-12379 (10g) is metabolized under the applied
PSB-12379, a nucleotide analogue, is a potent Ecto-5'-Nucleotidase ( CD73 ) inhibitor with K i s of 9.03 nM (rat) and 2.21 nM (human)In VitroMetabolism : Only a small percentage (<:23%) of PSB-12379 (10g) is metabolized under the applied
PSB-12379, a nucleotide analogue, is a potent Ecto-5'-Nucleotidase ( CD73 ) inhibitor with K i s of 9.03 nM (rat) and 2.21 nM (human)In VitroMetabolism : Only a small percentage (<:23%) of PSB-12379 (10g) is metabolized under the applied
PSB-12379, a nucleotide analogue, is a potent Ecto-5'-Nucleotidase ( CD73 ) inhibitor with K i s of 9.03 nM (rat) and 2.21 nM (human)In VitroMetabolism : Only a small percentage (<:23%) of PSB-12379 (10g) is metabolized under the applied
PSB-12379, a nucleotide analogue, is a potent Ecto-5'-Nucleotidase ( CD73 ) inhibitor with K i s of 9.03 nM (rat) and 2.21 nM (human)In VitroMetabolism : Only a small percentage (<:23%) of PSB-12379 (10g) is metabolized under the applied
PSB-12379, a nucleotide analogue, is a potent Ecto-5'-Nucleotidase ( CD73 ) inhibitor with K i s of 9.03 nM (rat) and 2.21 nM (human)In VitroMetabolism : Only a small percentage (<:23%) of PSB-12379 (10g) is metabolized under the applied